BPH - Benign Prostatic Enlargement

Symptomatic Benign Prostate Hyperplasia May Increase the Risk of Kidney Stones. May 31, 2026

Targeting fibrosis in the treatment of lower urinary tract dysfunction. May 31, 2026

Comparison of Robotic vs Laser Enucleation of the Prostate for Treatment of Benign Prostatic Hyperplasia. May 25, 2026

Transperineal Laser Ablation of Symptomatic Benign Prostatic Hyperplasia With Median-Lobe Enlargement: A Single-Center Experience. May 24, 2026

Quantitative CT biomarkers for predicting clinical outcomes after prostatic artery embolization: Results of the prospective pilot EMBOPERF study. May 24, 2026

Predictors of Medication Cessation After Benign Prostatic Hyperplasia Procedures. May 18, 2026

Sexual function outcomes of the 5-year treatment with Rezum compared to doxazosin, finasteride, and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of Prostatic Symptoms Trial. May 17, 2026

External validation of the prostatic inflammation nomogram to predict prostatic inflammation in men with lower urinary tract symptoms. May 17, 2026

Urodynamic de-obstruction and symptom improvement after thulium laser vaporization (ThuVAP): evidence from a prospective paired study. May 11, 2026

Face and content validation of laser enucleation of prostate simulation model: an EAU European School of Urology (ESU) Lower Urinary Tract Endoscopy Working Group study. May 10, 2026

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management. May 31, 2026

Comparison of Urodynamic Outcomes of Surgery Using the Photoselective Vaporization 180 W XPS System and Transurethral Resection of the Prostate: A Propensity Score-Matched Analysis in Real-World Clinical Practice. May 31, 2026

Antifibrotic therapy for Lower Urinary Tract Symptoms secondary to Benign Prostatic Hyperplasia. May 24, 2026

Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence. May 24, 2026

Clinical outcomes of benign prostatic hyperplasia surgery in men with detrusor underactivity versus normal contractility: a systematic review and meta-analysis. May 18, 2026

Efficacy and safety of modified transurethral thulium laser enucleation-resection with apical vaporization cutting versus anatomic thulium laser enucleation for large-volume (> 80 ml) benign prostatic hyperplasia: A retrospective comparative study. May 17, 2026

Preclinical Evaluation of Dual-Fiber Laser Ablation for Controlled Thermal Necrosis in Bovine Prostate Tissue Using the EchoLaser X4 System. May 17, 2026

Holmium laser enucleation of the prostate after prostatic urethral lift: the state of bother. May 11, 2026

Predictors of durability of the prostatic urethral lift (PUL) for benign prostatic hyperplasia. May 11, 2026

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III: Procedural/Surgical Management. May 10, 2026

Page 1 of 167